Literature DB >> 12359509

Angiotensin mutant mice: a focus on the brain renin-angiotensin system.

Satoshi Morimoto1, Curt D Sigmund.   

Abstract

With advances in genetic manipulation and molecular biological and physiological techniques, the mouse has become the animal model of choice for studying the genetic basis of human diseases. The two most commonly used methods for analyzing the function of a gene in vivo, overexpression (transgenic mouse) and deletion (knockout mouse), have been extremely useful in establishing the importance of genes in genetic disorders. The renin-angiotensin system (RAS) is one of the most widely studied systems controlling blood pressure. Although the primary site of Ang-II production is the plasma, all the components of the RAS cascade are expressed in many tissues, including the brain. This review briefly summarizes systemic and tissue-specific transgenic and knockout mouse models of the RAS for determining the role of this system in the regulation of blood pressure and in the pathogenesis of hypertension, with a focus on the RAS in the brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359509     DOI: 10.1054/npep.2002.0894

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  10 in total

1.  Luminal ANG II is internalized as a complex with AT1R/AT2R heterodimers to target endoplasmic reticulum in LLC-PK1 cells.

Authors:  Fernanda M Ferrão; Luiza H D Cardoso; Heather A Drummond; Xiao C Li; Jia L Zhuo; Dayene S Gomes; Lucienne S Lara; Adalberto Vieyra; Jennifer Lowe
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-03

Review 2.  Hypothalamic inflammation: a double-edged sword to nutritional diseases.

Authors:  Dongsheng Cai; Tiewen Liu
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

3.  Activation of the (pro)renin receptor in the paraventricular nucleus increases sympathetic outflow in anesthetized rats.

Authors:  Michael J Huber; Rupsa Basu; Cassie Cecchettini; Adolfo E Cuadra; Qing-Hui Chen; Zhiying Shan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-06-26       Impact factor: 4.733

4.  A fluorogenic near-infrared imaging agent for quantifying plasma and local tissue renin activity in vivo and ex vivo.

Authors:  Jun Zhang; Dorin V Preda; Kristine O Vasquez; Jeff Morin; Jeannine Delaney; Bagna Bao; M David Percival; Daigen Xu; Dan McKay; Michael Klimas; Bohumil Bednar; Cyrille Sur; David Z Gao; Karen Madden; Wael Yared; Milind Rajopadhye; Jeffrey D Peterson
Journal:  Am J Physiol Renal Physiol       Date:  2012-06-06

Review 5.  Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases.

Authors:  Erin G Rosenbaugh; Krupa K Savalia; Devika S Manickam; Matthew C Zimmerman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-04-03       Impact factor: 3.619

6.  Characterization of a functional (pro)renin receptor in rat brain neurons.

Authors:  Zhiying Shan; Adolfo E Cuadra; Colin Sumners; Mohan K Raizada
Journal:  Exp Physiol       Date:  2008-03-07       Impact factor: 2.969

Review 7.  A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link?

Authors:  Adolfo E Cuadra; Zhiying Shan; Colin Sumners; Mohan K Raizada
Journal:  Pharmacol Ther       Date:  2009-08-31       Impact factor: 12.310

8.  Angiotensin II induces cell growth and IL-6 mRNA expression through the JAK2-STAT3 pathway in rat cerebellar astrocytes.

Authors:  Umadevi Kandalam; Marimuthu Palanisamy; Michelle A Clark
Journal:  JAKSTAT       Date:  2012-04-01

9.  Effects of Phytochemicals on Blood Pressure and Neuroprotection Mediated Via Brain Renin-Angiotensin System.

Authors:  Hae Rin Kim; Woo Kyoung Kim; Ae Wha Ha
Journal:  Nutrients       Date:  2019-11-14       Impact factor: 5.717

10.  Brain angiotensin-converting enzymes: role of angiotensin-converting enzyme 2 in processing angiotensin II in mice.

Authors:  Khalid M Elased; Tatiana Sousa Cunha; Fernanda Klein Marcondes; Mariana Morris
Journal:  Exp Physiol       Date:  2008-02-08       Impact factor: 2.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.